not losing weight on semaglutide should i switch to tirzepatide Switching from what is the difference between

The GLP-1 receptor activation enhances glucose-stimulated insulin secretion, slows gastric emptying , and promotes satiety

Whether it lives up to its Phase 2 and Phase 3 promise across the full TRIUMPH program will determine whether it becomes the new standard of care or remains one option among several

Oral GLP-1 therapies are poised to expand access across obesity, pre-diabetes, and early T2D markets

Combining semaglutide with resistance training, adequate protein intake (1.2-1.6g per kg body weight daily), and periodic increases in physical activity counters metabolic slowdown and restarts weight loss plateaus

Participants saw significant reductions in fasting insulin, improvements in HbA1c levels even in non-diabetic participants, reductions in triglycerides, and improvements in systolic and diastolic blood pressure